Sarepta Therapeutics (SRPT) Superinvestor holders
16 of the superinvestors we track hold Sarepta Therapeutics (SRPT) in their latest 13F filings, $256M in total.
Summary
The largest holder is Two Sigma (Two Sigma Investments), with $83M, 0.1% of the portfolio.
In their latest quarter: 2 opened a new position, 6 added, 7 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Two Sigma Two Sigma Investments |
Added | 4,598,735 | $83M | 0.1% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Trimmed | 4,325,689 | $77M | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
Added | 2,206,022 | $40M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 1,121,378 | $20M | 0.0% | Q2 2026 |
| Hotchkis & Wiley Hotchkis & Wiley Capital Management |
Added | 565,720 | $10M | 0.0% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
New position | 510,908 | $9M | 0.0% | Q2 2026 |
| Man Group Man Group plc |
Added | 398,144 | $7M | 0.0% | Q2 2026 |
| David Vogel Voloridge Investment Management |
Trimmed | 262,565 | $5M | 0.0% | Q2 2026 |
| Ray Dalio Bridgewater Associates |
Added | 152,068 | $3M | 0.0% | Q2 2026 |
| Ken Tropin Graham Capital Management |
Added | 31,192 | $560,520 | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
Trimmed | 30,928 | $555,776 | 0.0% | Q2 2026 |
| Didric Cederholm Lion Point Capital |
Held | 28,500 | $512,145 | 2.5% | Q2 2026 |
| Alec Litowitz Magnetar Capital |
New position | 16,551 | $297,421 | 0.0% | Q2 2026 |
| Peter Muller PDT Partners |
Trimmed | 15,800 | $283,926 | 0.0% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Trimmed | 6,093 | $109,491 | 0.0% | Q2 2026 |
| Fred DiSanto Ancora Holdings |
Trimmed | 2,500 | $44,925 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 17 |
| Q1 2026 | 17 |
| Q4 2025 | 15 |
| Q3 2025 | 13 |
| Q2 2025 | 10 |
| Q1 2025 | 18 |
| Q4 2024 | 17 |
| Q3 2024 | 20 |
Questions about Sarepta Therapeutics
Which superinvestors own Sarepta Therapeutics?
16 of the superinvestors we track hold Sarepta Therapeutics (SRPT) in their latest 13F filings, $256M in total. Two Sigma, Cliff Asness, Paul Marshall, Jim Simons, Hotchkis & Wiley, Steve Cohen.
Who is the largest superinvestor holder of SRPT?
The largest holder is Two Sigma (Two Sigma Investments), with $83M, 0.1% of the portfolio.
From Sarepta Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.